ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer.
Scott T Tagawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.